About AmCad BioMed
AmCad BioMed Corporation, founded in 2008 and publicly traded on the Taipei Exchange (Ticker: 4188), is a pioneering medical imaging AI company specializing in ultrasound-based diagnostic solutions. Headquartered in Taiwan, the company develops patented artificial intelligence technologies that integrate with ultrasound imaging to support early disease detection and improve diagnostic consistency across multiple clinical applications. The company's flagship products include AmCAD-UO for obstructive sleep apnea assessment, AmCAD-UT for thyroid nodule evaluation, AmCAD-UB for breast imaging with BI-RADS insights, and AmCAD-US for general soft tissue analysis. AmCad BioMed delivered the world's first ultrasound AI solution and holds multiple FDA and CE certifications for its products. The company's technology enables real-time quantification and visualization during ultrasound examinations, helping clinicians detect diseases faster and interpret images with greater accuracy. AmCad BioMed serves over 130 healthcare institutions worldwide, addressing critical diagnostic challenges including the 30% of thyroid nodules that are indeterminate by conventional ultrasound, the 80% of OSA cases that go undiagnosed, and the 50% of breast cancers missed in women with dense breast tissue. The company maintains strong commitments to research and development, ESG principles, and expanding global access to smart healthcare solutions, including through handheld ultrasound systems for underserved and remote areas.
Mission & Story
Mission
To address unmet clinical needs with smart technologies, focusing on AI-powered ultrasound imaging for diagnosis and clinical adoption, while fulfilling responsibilities to society and the environment
Founding Story
Founded in 2008 by C.C. Lee (Founder) with Yi-Li Lee serving as Chairperson/President. The company was established to integrate artificial intelligence with ultrasound imaging to enable real-time quantification and visualization for improved diagnostic accuracy.
Clinical Focus
Medical conditions and clinical areas addressed by AmCad BioMed.
Who It Serves
Milestones & Awards
Recent Milestones
Published research in Sleep Medicine journal with Stanford Sleep Center (2025). Published study in Otolaryngology–Head and Neck Surgery with Bern University Hospital showing AmCAD-UO's value in predicting OSA treatment success. Launched handheld ultrasound (POCUS) system with AI guidance (2024). Organized 28 clinical education sessions, 9 academic exchanges, and 5 corporate health screening programs in 2024. Exhibited at WDSS, World Sleep 2025, ISSS 2024.
Awards & Recognition
2021 Taiwan Excellence Award (AmCAD-CA), 2019 Drug Research and Development Science and Technology Award (AmCAD-UO), 2018 Taiwan Excellence Award (AmCAD-UT), 2016 Frost & Sullivan Taiwan Excellence Awards, 2016 National Innovation Award (AmCAD-CA), 2013 Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Award
Key Partnerships
Social & Media
Latest Updates
Company Details
- Founded
- 2008
- Headquarters
- Taiwan
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.